NYC Digital Health Raised $2.4B in H1 2025: The Sector Data Every Founder Should Know

NYC digital health grew 10% YoY in H1 2025 to $2.4B raised. Life sciences broadly captured 27% of all NYC venture funding. Here’s why the sector is a durable growth story.

The data

• $2.4B — NYC digital health H1 2025 total (+10% YoY).
• 27% — Life sciences/biotech share of NYC VC H1 2025.
• #1 — NYC hospital system density in the U.S. (by population served).
• 1.08M jobs — Healthcare + Social Assistance in NYC (Aug 2025, NYCEDC).

Why NYC is a natural health hub

1. Hospital density: Mount Sinai, NYU Langone, NewYork-Presbyterian, Columbia, Weill Cornell, Memorial Sloan Kettering — world-class systems concentrated in a 10-mile radius.
2. Research universities: Columbia, Cornell, NYU, Rockefeller.
3. Payer diversity: Commercial insurers, Medicaid plans, Medicare Advantage plans — strong testing ground.
4. Clinical talent pipeline: Residents, fellows, researchers who stay in NYC.
5. Investor cluster: OrbiMed (NYC-HQ), Deerfield, Perceptive Advisors — some of the largest public/private health investors.

Major NYC health investors in 2026

• OrbiMed — $20B+ AUM, NYC-HQ, life sciences breadth.
• Deerfield Management — NYC-HQ, public/private health.
• Perceptive Advisors — crossover biotech.
• Flare Capital Partners (Boston but NYC-active).
• .406 Ventures — digital health + cyber + cloud.
• Casdin Capital — life sciences hedge + VC.
• General Catalyst — health system partnerships model.
• Thrive Capital — Isomorphic Labs lead.

Recent NYC health deals (2025–2026)

• Avo — $10M Series A in clinical AI.
• Patlytics — Series A for patent + clinical intelligence.
• Faireez — seed for compliance-adjacent care.
• Hiveclass — seed.
• Junction — Series A.

NYC health themes that rank highly for VCs

1. Workflow AI: Documentation, coding, prior auth, scheduling.
2. Revenue cycle: AI-driven billing + collections.
3. Specialty care platforms: Oncology, behavioral health, cardiology.
4. Value-based care enablement: Risk-bearing software.
5. AI drug discovery (Isomorphic NYC presence, Insilico partnerships).

Data on health-VC returns

Cambridge Associates’ 2025 data shows that healthcare + IT + industrials together account for 85% of U.S. VC invested capital, with healthcare deal sizes growing consistently. NYC’s health VC share of this is disproportionately large for its population.

Practical takeaway

• Founders: Health startups built near NYC hospitals have faster initial adoption. Co-locate early customers.
• Investors: NYC digital health is Series A+ heavy; seed rounds benefit from operator-angels (physicians, hospital execs).
• LPs: Allocate to sector-specialist NYC funds rather than generalist for health exposure.

Sources

1. Crain’s NY — Digital Health 2025: https://www.crainsnewyork.com/health-pulse/nycs-digital-health-sector-sees-slight-funding-uptick-2025/
2. NYCEDC State of the Economy 2025: https://edc.nyc/sites/default/files/2025-12/NYCEDC-2025-State-of-NYC-Economy_12-12-2025.pdf
3. Cambridge Associates H1 2025: https://www.cambridgeassociates.com/insight/us-pe-vc-benchmark-commentary-first-half-2025/